KOBOLD SURE-GUIDE VAGINAL CYLINDER SET, STUMP VAGINAL CYLINDER SET, MIAMI CYLINDER SET

K123941 · Spencer Fillmore · JAQ · Apr 30, 2013 · Radiology

Device Facts

Record IDK123941
Device NameKOBOLD SURE-GUIDE VAGINAL CYLINDER SET, STUMP VAGINAL CYLINDER SET, MIAMI CYLINDER SET
ApplicantSpencer Fillmore
Product CodeJAQ · Radiology
Decision DateApr 30, 2013
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 892.5700
Device ClassClass 2
AttributesTherapeutic

Intended Use

The CT/MRI Compatible Sure-guide Vaginal Cylinder Set is indicated for use in any patient case where High Dose Rate (HDR) radiation treatment of the vagina is acceptable by up-to-date clinical and practice guidelines. The CT/MRI Compatible Sure-guide Stump Vaginal Cylinder Set is indicated for use in any patient case where High Dose Rate (HDR) radiation treatment of the vagina is acceptable by up-to-date clinical and practice guidelines. The CT/MRI Compatible Miami HDR Set is indicated for use in any patient case where High Dose Rate (HDR) radiation treatment of the cervix, vagina, and uterus is acceptable by up-to-date clinical and practice guidelines.

Device Story

Applicator sets for High Dose Rate (HDR) brachytherapy; used for definitive, adjuvant, or boost radiation treatment. Devices consist of precision-manufactured cylinders of varied diameters for anatomical customization; Miami set includes intrauterine tandems with varying curvatures to accommodate uterine flexure. Features click-fit connector interface for compatibility with GammaMed and VariSource afterloaders. Used in clinical settings by radiation oncology staff. Provides physical guidance for radiation source delivery to target tissues (vagina, cervix, uterus). CT/MRI compatibility allows for image-guided treatment planning. Benefits include optimal radiation delivery and customization for patients with limited or narrow vaginal vault space due to tumor, fibrosis, or restricted anatomy.

Clinical Evidence

Bench testing only. No clinical data provided. Testing included mechanical performance, cleaning/sterilization validation, and biocompatibility assessment in accordance with recognized standards.

Technological Characteristics

Materials: Titanium, Ultem, Silicone, High Temperature Vinyl, Stainless Steel. Design: Cylindrical HDR delivery system with click-fit connector. Compatibility: CT/MRI compatible. Sterilization: Steam (18 min at 273°F/134°C, 44psi). Form factor: Variable diameter cylinders and intrauterine tandems.

Indications for Use

Indicated for patients requiring High Dose Rate (HDR) radiation treatment of the vagina (Vaginal and Stump sets) or the cervix, vagina, and uterus (Miami set) as determined by clinical guidelines.

Regulatory Classification

Identification

A remote controlled radionuclide applicator system is an electromechanical or pneumatic device intended to enable an operator to apply, by remote control, a radionuclide source into the body or to the surface of the body for radiation therapy. This generic type of device may include patient and equipment supports, component parts, treatment planning computer programs, and accessories.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ K123941 # APR 3 0 2013 # 510(k) Summary This summary of 510(k) safety and effectiveness information is furnished in accordance with requirements detailed in 21 CFR 807.92. l . The assigned 510(k) number is K-TBD Submitter's Identification: Spencer Fillmore 2410 S Sumner Lane Greenacres, WA, 99016 Correspondence: Christina Bernstein BB Medical Surgical, Inc. 2670 Leavenworth Street San Francisco, CA 94133 Tel: 415-450-0515 Email tina@bbmedicalsurgical.com Date of submission 14 December 2012 2. Device name: l. Vaginal Cylinders Proprietary name: Kobold Sure-guide Vaginal Cylinder Set™ 2. Stump Cylinders Proprietary name: Kobold Sure-guide Stump Vaginal Cylinder Set™ 3. Miami Cylinders Proprietary name: Kobold Sure-guide Miami Cylinder Set™ - A. Regulation Section 892.5700 - B. Classification: Class II - C. Product Code: JAQ - D. Panel: Radiology 7 {1}------------------------------------------------ #### Kobold Cylinders 3. Intended Use: ### Vaginal The CT/MRI Compatible Sure-guide Vaginal Cylinder Set is indicated for use in any patient case where High Dose Rate (HDR) radiation treatment of the vagina is acceptable by up-to-date clinical and practice guidelines. ## Stump The CT/MRI Compatible Sure-guide Stump Vaginal Cylinder Set is indicated for use in any patient case where High dose Rate (HDR) radiation treatment of the vagina is acceptable by up-to-date clinical and practice guidelines. ### Miami The CT/MRI Compatible Miami HDR Set is indicated for use in any patient case where High Dose Rate (HDR) radiation treatment of the cervix, vagina, and uterus is acceptable by up-to-date clinical and practice guidelines. #### 4. Device Description: l . Vaginal The CT/MRI compatible Sure-guide Vaginal Cylinder Set design is based on conventional cylindrical HDR delivery systems with a click fit connector interface. This applicator is particularly useful in providing an HDR radiation as definitive treatment, adjuvant treatment, or as a treatment boost to the vaginal walls with or without external beam radiation therapy. The set consists of a precision manufactured Sure-guide cylinders of varied diameters for optimal radiation treatment delivery and anatomical customization. ### 2. Stump The CT/MRI Compatible Sure-guide Stump Vaginal Cylinder Set design is based on conventional cylindrical HDR delivery systems with a click fit connector interface. This applicator is particularly useful in providing an HDR radiation as definitive treatment, adjuvant treatment, or as a treatment boost to the vaginal walls with or without external beam radiation therapy. The set consists of a precision-manufactured 8 {2}------------------------------------------------ Kobold Cylinders Sure-guide Stump Cylinders of varied diameters for optimal radiation treatment delivery and anatomical customization. ### 3. Miami The CT/MRI Compatible Sure-guide Miami HDR applicator Set is designed according to the conventional modified Miami applicator with a click fit connector interface. This applicator is particularly useful when the vaginal vault space is limited or narrow due to tumor, restricted anatomy, or fibrosis. It can also be useful to treat tumors that extend from the uterus or cervix down onto the vaginal wall. The set consists of a precision manufactured intrauterine tandems and a full set of variable diameter Miami cylinders (all components are designed to allow for customization of the treated geometry). The distance that the tandem is inserted can be customized for each case. Four differing tandems are provided: one straight, one slight curvature, one medium curvature, and one maximal curvature. These allow for maximal accommodation of the uterine flexure. ### 5. #### Substantial Equivalence Information: Information presented supports substantial equivalence of the Kobold Sure-guideTM Vaginal. Stump and Miami versions of the cvlinder set to the predicate device. Each of the proposed versions of the device has the same indications for use, has similar nature of body contact, is similar in shape and design, has the same fundamental technology and uses the same sterilization procedures. Please see predicate device description in Appendix C. - A. Predicate device names: Intracavity BrachyTherapy Applicators - B. Predicate device K numbers: K-033371 - Comparison with predicate: ். | SUBSTANTIAL<br>EQUIVALENCE<br>TABLE | KOBOLD LLC | KOBOLD LLC | KOBOLD LLC | VARIAN, INC.® | |-----------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | K-Number | TBD | TBD | TBD | K-033371 | | Device Description | Cylinder Set,<br>Vaginal | Cylinder Set,<br>Stump Vaginal | Cylinder Set<br>Miami | Cylinder Set,<br>Vaginal, Stump,<br>Cervical (Miami) | | Indications for Use | The CT/MRI<br>Compatible Sure-<br>guide Vaginal<br>Cylinder Set is<br>indicated for use in<br>any patient case<br>where High Dose<br>Rate (HDR)<br>radiation treatment<br>of the vagina is<br>acceptable by up-<br>to-date clinical and<br>practice<br>guidelines. | The CT/MRI<br>Compatible Sure-<br>guide Stump<br>Vaginal Cylinder<br>Set is indicated for<br>use in any patient<br>case where High<br>dose Rate (HDR)<br>radiation treatment<br>of the vagina is<br>acceptable by up-<br>to-date clinical and<br>practice guidelines. | The CT/MRI<br>Compatible<br>Miami HDR Set<br>is indicated for<br>use in any patient<br>case where High<br>Dose Rate<br>(HDR) radiation<br>treatment of the<br>cervix, vagina,<br>and uterus is<br>acceptable by<br>up-to-date<br>clinical and<br>practice<br>guidelines. | Vaginal Applicator<br>Set is developed for<br>intracavity<br>brachytherapy to<br>treat cancer of the<br>vagina or rectum.<br>The maximum<br>implantation time<br>for this applicator is<br>30 days. | | Afterloader<br>Compatibility | GammaMed®,<br>VariSource® with<br>click-fit connector. | GammaMed®,<br>VariSource® with<br>click-fit connector. | GammaMed®,<br>VariSource®<br>with click-fit<br>connector. | GammaMed®,<br>VariSource® with<br>click-fit connector. | | Materials | Titanium, Ultem®,<br>Silicone, High<br>Temperature Vinyl | Titanium, Ultem®,<br>Silicone, High<br>Temperature Vinyl | Titanium,<br>Ultem®, Silicone,<br>High<br>Temperature<br>Vinyl, Stainless<br>Steel | PPSU, PVDF,<br>Acetal, Stainless<br>Steel, PEEK | | Packing | Tray | Tray | Tray | Not Documented | | Sterility | Provided Non-<br>Sterile | Provided Non-<br>Sterile | Provided Non-<br>Sterile | Provided Non-<br>Sterile | | Sterilization<br>Methods,<br>Sterilization<br>Conditions, | Steam 18 min at<br>273°F (134°C),<br>44psi (3 bar) Dry<br>15 min. | Steam 18 min at<br>273°F (134°C),<br>44psi (3 bar) Dry<br>15 min. | Steam 18 min at<br>273°F (134°C),<br>44psi (3 bar) Dry<br>15 min. | Steam Sterilizable | | Biocompatibility | Documented | Documented | Documented | Not Documented | | Anatomical Sites | vagina | vagina | cervix, vagina,<br>and uterus | cervix, vagina, and<br>uterus | | Environmental<br>Compatibility | CT/MRI<br>Compatible | CT/MRI<br>Compatible | CT/MRI<br>Compatible | CT/MRI Compatible | {3}------------------------------------------------ # Kobold Cylinders 10 ・ {4}------------------------------------------------ ### 6. ### Test Principle, Performance Characteristics: FDA has not established special controls or performance standards for this device. ## 7. Bench Top Testing Extensive testing in accordance with known standards is documented by the manufacturer. The standards are specifications for the materials used in surgical implant applications, predicate brachytherapy devices and manufacturer's acceptance procedures. Mechanical testing of the finished devices is additionally described in Appendix A. Cleaning/Sterilization validation test results are also included. ### 8. ### Conclusions All versions of Kobold's Sure-guide Cylinder Set™ are similar in intended use and technological characteristics to predicate devices reviewed. Each version of the device is similar with respect to indications for use and physical characteristics to predicate devices in terms of section 510(k) substantial equivalency. Contraindications: As per clinical guidelines and standard clinical practice. Warnings and Precautions: The precautions are provided in the device labeling for the Kobold Sure-guide Vaginal Cylinder Set™ , Kobold Sure-guide Stump Vaginal Cylinder Set™ and Kobold Sure-guide Miami Cylinder Set™. There is no warning associated with this type of device. ### 9. Summary | Description | Comparison with Predicate Device | |-----------------------------|----------------------------------| | Biocompatibility | Safe as Predicate Device | | Performance Characteristics | Substantially equivalent | | Intended Use | Substantially equivalent | | Performance Tests | Not Required | Each version of the device, Kobold Sure-guide Vaginal Cylinder Set™ , Kobold Sureguide Stump Vaginal Cylinder Set™ and Kobold Sure-guide Miami Cylinder Set™, based on the information submitted in this 510(k) application has been demonstrated to be substantially equivalent to the predicate devices. {5}------------------------------------------------ ### DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 April 30, 2013 Kobold, LLC % Ms. Christina Bernstein Regulatory Director 2670 Leavenworth Street San Francisco, CA 94133 Re: K123941 Trade/Device Name: Kobold Sure-guide Vaginal Cylinder Set™ Kobold Sure-guide Stump Vaginal Cylinder Set™ Kobold Sure-guide Miami Cylinder Set™ Regulation Number: 21 CFR 892.5700 Regulation Name: Remote Controlled Radionuclide Applicator System Regulatory Class: Class II Product Code: JAQ Dated: March 13, 2013 Received: March 18, 2013 Dear Ms. Bernstein: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must {6}------------------------------------------------ ### Page 2 - Ms. Christina Bernstein comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Sincerely yours. Michael D. D'Hara for Janine M. Morris, M.S. Director, Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health Enclosure {7}------------------------------------------------ ## Indications for Use 510(k) Number (if known): K123941 1. Device Name: Kobold Sure-guide Vaginal Cylinder Set™ Indications for Use: The CT/MRI Compatible Sure-guide Vaginal Cylinder Set is indicated for use in any patient case where High Dose Rate (HDR) radiation treatment of the vagina is acceptable by up-to-date clinical and practice guidelines. 2. Device Name: Kobold Sure-guide Stump Vaginal Cylinder Set™ Indications for Use: The CT/MRI Compatible Sure-guide Stump Vaginal Cylinder Set is indicated for use in any patient case where High Dose Rate (HDR) radiation treatment of the vagina is acceptable by up-to-date clinical and practice guidelines. 3. Device Name: Kobold Sure-guide Miami Cylinder Set™ Indications for Use: The CT/MRI Compatible Miami HDR Set is indicated for use in any patient case where High Dose Rate (HDR) radiation treatment of the cervix, vagina, and uterus is acceptable by up-to-date clinical and practice guidelines. Prescription Use X AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR) Michael D. O'Hara (Division Sign C Division of Radiological Health Office of In Vitro Diagnostic and Radiological Health 510(k)_______________________________________________________________________________________________________________________________________________________________________ K123941 Page I of
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...